Kellie McCormick Hallam

Kellie McCormick Hallam, PhD has a diverse work experience in the scientific and healthcare industry. Kellie started their career at UC Davis, where they worked as a Physiology Graduate Student, conducting research on congestive heart failure and facilitating clinical trials on the effects of meditation and chocolate consumption on cardiovascular health. Kellie then joined Columbia University as a Postdoctoral Scientist, focusing on in vivo target validation of pharmacological interventions for cardiovascular disease and diabetes.

In 2006, Kellie moved to Ogilvy Healthworld, where they held various roles including Senior Scientific Associate, Scientific Associate, Scientific Supervisor, and Vice President, Group Scientific Supervisor. Kellie'sresponsibilities included supervising scientific projects and conducting research in the healthcare field.

In 2015, they joined ApotheCom: A Huntsworth Health Company as the VP, Scientific Strategy, where they played a key role in developing scientific strategies for healthcare campaigns.

Currently, Kellie works at Lockwood as the GVP, Scientific Services, overseeing scientific services and leading strategic initiatives. Kellie has also held roles as SVP, Group Scientific Director and VP, Group Scientific Supervisor at Lockwood.

Overall, Kellie McCormick Hallam, PhD has a strong background in scientific research, project management, and strategic planning, making their an invaluable asset in the healthcare industry.

Kellie McCormick Hallam, PhD completed their Doctor of Philosophy (Ph.D.) degree in Molecular, Cellular and Integrative Physiology from the University of California, Davis, where they attended from 1995 to 1999. Following this, from 2004 to 2006, Hallam pursued a postdoctoral program in Internal Medicine at Columbia University.